Eisai (Two Central Nervous System Products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Eisai (Two Central Nervous System Products) General Information

Description

Portfolio of two central nervous system (CNS) medicines. The medicines address Parkinson's disease and psychotic disorders which provide effective treatment options for patients experiencing motor impairments and mental health challenges.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • France
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eisai (Two Central Nervous System Products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eisai (Two Central Nervous System Products)‘s full profile, request access.

Request a free trial

Eisai (Two Central Nervous System Products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Eisai (Two Central Nervous System Products)‘s full profile, request access.

Request a free trial

Eisai (Two Central Nervous System Products) FAQs

  • Where is Eisai (Two Central Nervous System Products) headquartered?

    Eisai (Two Central Nervous System Products) is headquartered in France.

  • What industry is Eisai (Two Central Nervous System Products) in?

    Eisai (Two Central Nervous System Products)’s primary industry is Buildings and Property.

  • Is Eisai (Two Central Nervous System Products) a private or public company?

    Eisai (Two Central Nervous System Products) is a Private company.

  • What is the current valuation of Eisai (Two Central Nervous System Products)?

    The current valuation of Eisai (Two Central Nervous System Products) is .

  • What is Eisai (Two Central Nervous System Products)’s current revenue?

    The current revenue for Eisai (Two Central Nervous System Products) is .

  • Who are Eisai (Two Central Nervous System Products)’s investors?

    Eisai has invested in Eisai (Two Central Nervous System Products).

  • When was Eisai (Two Central Nervous System Products) acquired?

    Eisai (Two Central Nervous System Products) was acquired on 28-Mar-2024.

  • Who acquired Eisai (Two Central Nervous System Products)?

    Eisai (Two Central Nervous System Products) was acquired by CNX Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process